• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Initial H1N1 Patient Information Helped Guide Outbreak Response in NYC

Pathfinder

Editor, Senior Moderator
From Medscape Medical News

Initial H1N1 Patient Information Helped Guide Outbreak Response in NYC

Emma Hitt, PhD
Authors and Disclosures

January 7, 2010 ? A medical record review of the first 99 patients with 2009 pandemic influenza A (H1N1) hospitalized in New York City (NYC) has helped guide subsequent efforts against the pandemic, according to a study conducted by the NYC Department of Health and Mental Hygiene (DOHMH).

The study is published in the January 8 issue of the Morbidity and Mortality Weekly Report.

The authors, led by Meredith E. Slopen, MSW, with the NYC DOHMH, concluded from the findings that public education campaigns should "encourage patients at high risk of severe illness to be vaccinated, and should emphasize to medical providers the importance of early antiviral therapy for children aged <2 years and patients with underlying risk conditions."

The analysis assessed disease and patient characteristics of the first patients with H1N1 influenza. Medical record information was collected within about 2 weeks and included patient demographics, disease severity, and use of antiviral medications.

Among the 99 patients, about 60% were younger than 18 years and 91% were younger than 50 years.

The most frequently reported underlying condition was asthma, observed in about half of the patients. Other patients (17%) had multiple underlying conditions (asthma, chronic metabolic disorder, and/or renal disease plus immunosuppressive conditions).

Patients receiving oseltamivir within 2 days of the onset of symptoms had shorter hospitalizations than patients who received treatment on day 3 or later (P = .03). According to the report, this finding "generally supported DOHMH's public health messages that persons with underlying conditions should seek care as early as possible."

Among obese adults, 92% had an underlying condition that could increase the risk for severe influenza or complications. Of the 4 deaths observed, 3 occurred in obese individuals.

"Whether obesity itself contributes to the risk of acquiring H1N1 influenza or to the risk of severe disease or death remains unclear but has been a focus of investigation during the H1N1 pandemic," the study authors point out in the editorial note. They suggest that height and weight should be documented in the records of all hospitalized patients with H1N1 influenza.
Morb Mortal Wkly Rep. 2010;58:1436-1440.

http://www.medscape.com/viewarticle/714782
 
Back
Top